These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 847756)

  • 1. The role of biliary excretion in the hepatotoxicity of furosemide in the mouse.
    Spitznagle LA; Wirth PJ; Boobis SW; Thorgeirsson SS; Nelson WL
    Toxicol Appl Pharmacol; 1977 Feb; 39(2):283-94. PubMed ID: 847756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical pharmacology of furosemide].
    Prandota J; Witkowska M
    Pol Tyg Lek; 1977 Sep; 32(39):1529-32. PubMed ID: 335364
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine.
    McMurtry RJ; Mitchell JR
    Toxicol Appl Pharmacol; 1977 Nov; 42(2):285-300. PubMed ID: 595008
    [No Abstract]   [Full Text] [Related]  

  • 4. Biliary excretion of sulfated bile acids and organic anions in zone 1- and zone 3-injured rats.
    Sasamoto T; Sano N; Takikawa H
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):26-31. PubMed ID: 16706808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite.
    Mitchell JR; Nelson WL; Potter WZ; Sasame HA; Jollow DJ
    J Pharmacol Exp Ther; 1976 Oct; 199(1):41-52. PubMed ID: 978483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of furosemide in functionally hepatectomized dogs.
    Verbeeck RK; Gerkens JF; Wilkinson GR; Branch RA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):479-83. PubMed ID: 7205627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
    Berenson MM; Welch V; Garcia-Marin JJ
    J Lab Clin Med; 1991 Jul; 118(1):89-98. PubMed ID: 2066649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of pretreatment with phenobarbital (PB) and sulfobromophthalein (BSP) on the metabolism and the biliary excretion of BSP in the rat.
    Schulze PJ; Czok G; Keller E
    Arzneimittelforschung; 1979; 29(10):1521-8. PubMed ID: 583215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Excretion of 131I-labeled bromsulphalein in rats with experimental liver injury].
    Hrncír E; Hykes P; Friedman B
    Sb Lek; 1986 Feb; 88(2):33-41. PubMed ID: 3961415
    [No Abstract]   [Full Text] [Related]  

  • 10. An experimental study of furosemide induced hepatotoxicity.
    Mehrotra R; Tandon P; Nath P
    Indian J Pathol Microbiol; 1986 Jul; 29(3):271-6. PubMed ID: 3817957
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitory effect of sulfobromophthalein (BSP) on the hepatic uptaic and biliary excretion of 99mTc-HIDA in rats (author's transl)].
    Kitani K; Minoda Y; Sasaki Y; Someya K
    Kaku Igaku; 1978 Oct; 15(7):999-1003. PubMed ID: 739682
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholestasis induced by model organic anions protects from acetaminophen hepatotoxicity in male CD-1 mice.
    Silva VM; Hennig GE; Manautou JE
    Toxicol Lett; 2006 Jan; 160(3):204-11. PubMed ID: 16140478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of organic anions on biliary glutathione excretion in rats.
    Takikawa H; Fujiyoshi M; Sano N; Yamanaka M
    Pharmacology; 1996 Aug; 53(2):114-22. PubMed ID: 8902876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of sulfobromophthalein in isolated perfused livers from normal and spironolactone-treated rats.
    Pellegrino JM; Mottino AD; Rodriguez JV; Rodriguez Garay EA
    Experientia; 1982 Jan; 38(1):112-4. PubMed ID: 7056350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furosemide induced hepatotoxicity.
    Walker RM; McElligott TF
    J Pathol; 1981 Dec; 135(4):301-14. PubMed ID: 7328448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic clearance of furosemide in the rat.
    Wallin JD; Ryals P; Kaplowitz N
    J Pharmacol Exp Ther; 1977 Jan; 200(1):52-7. PubMed ID: 833762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress.
    Lauterburg BH; Smith CV; Hughes H; Mitchell JR
    J Clin Invest; 1984 Jan; 73(1):124-33. PubMed ID: 6690473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 protects against furosemide-induced hepatotoxicity.
    Qu Q; Liu J; Zhou HH; Klaassen CD
    Toxicology; 2014 Oct; 324():35-42. PubMed ID: 24813929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones.
    Ando T; Kusuhara H; Merino G; Alvarez AI; Schinkel AH; Sugiyama Y
    Drug Metab Dispos; 2007 Oct; 35(10):1873-9. PubMed ID: 17639028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirex-induced impairment of hepatobiliary function. Suppressed biliary excretion of imipramine and sulfobromophthalein.
    Mehendale HM
    Drug Metab Dispos; 1977; 5(1):56-62. PubMed ID: 13976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.